Citation: TANG Jing-Long, WANG Shuo, LIU Li, WANG Chun-Ren, XI Ting-Fei. A Preliminary Study on the Dose-Effect Relation when Silver Nanoparticles Crossing through the Blood-Brain Barrier in vitro[J]. Chinese Journal of Inorganic Chemistry, 2013, 29(5): 1025-1030. doi: 10.3969/j.issn.1001-4861.2013.00.150
纳米银颗粒通过血脑屏障中剂量-效应关系的初步研究
-
关键词:
- 纳米银颗粒;血脑屏障;剂量-关系效应
English
A Preliminary Study on the Dose-Effect Relation when Silver Nanoparticles Crossing through the Blood-Brain Barrier in vitro
-
-
-
[1] Chen X, Schluesener H J. Toxicol Lett., 2008,176(1):1-12[1] Chen X, Schluesener H J. Toxicol Lett., 2008,176(1):1-12
-
[2] Martinez-Castanon G A, Nino-Martinez N, Martinez-Guiterrez F, et al. J. Nanoparticle Res., 2008,10(8):1343-1348[2] Martinez-Castanon G A, Nino-Martinez N, Martinez-Guiterrez F, et al. J. Nanoparticle Res., 2008,10(8):1343-1348
-
[3] Estores I M, Olsen D, Gómez-Marin O. J Rehabil Res Dev., 2008,45(1):135-139[3] Estores I M, Olsen D, Gómez-Marin O. J Rehabil Res Dev., 2008,45(1):135-139
-
[4] Vlachou E, Chipp E, Shale E, et al. Burns., 2007,3(8):979- 985[4] Vlachou E, Chipp E, Shale E, et al. Burns., 2007,3(8):979- 985
-
[5] Roe D, Karandikar B, Bonn-Savage N, et al. J Antimicrob Chemother., 2008,61(4):869-876[5] Roe D, Karandikar B, Bonn-Savage N, et al. J Antimicrob Chemother., 2008,61(4):869-876
-
[6] Takenaka S, Karg E, Roth C, et al. Environ. Health Perspect., 2001,109(Suppl 4):547-551[6] Takenaka S, Karg E, Roth C, et al. Environ. Health Perspect., 2001,109(Suppl 4):547-551
-
[7] Tang J L, Xiong L, Wang S, et al. J. Nanosci. Nanotechnol., 2009,9(8):4924-4932[7] Tang J L, Xiong L, Wang S, et al. J. Nanosci. Nanotechnol., 2009,9(8):4924-4932
-
[8] TANG Jing-Long(汤京龙), XI Ting-Fei(奚廷斐), WEI Li-Na (魏丽娜), et al. Chinese J. Inorg. Chem. (Wuji Huaxue Xuebao), 2008,24(11):1827-1831[8] TANG Jing-Long(汤京龙), XI Ting-Fei(奚廷斐), WEI Li-Na (魏丽娜), et al. Chinese J. Inorg. Chem. (Wuji Huaxue Xuebao), 2008,24(11):1827-1831
-
[9] Tang J L, Xiong L, Wang S, et al. Appl. Surface Sci., 2008,255(2):502-504[9] Tang J L, Xiong L, Wang S, et al. Appl. Surface Sci., 2008,255(2):502-504
-
[10] TANG Jing-Long(汤京龙), XI Ting-Fei(奚廷斐), XIONG Ling(熊玲),et al. Transact. Mater. Heat Treat. (Cailiao Rechuli Xuebao), 2009,30(3):6-9[10] TANG Jing-Long(汤京龙), XI Ting-Fei(奚廷斐), XIONG Ling(熊玲),et al. Transact. Mater. Heat Treat. (Cailiao Rechuli Xuebao), 2009,30(3):6-9
-
[11] Tang J L, Xiong L, Zhou G F,et al. J. Nanosci. Nanotechnol., 2010,10(10):6313-6317[11] Tang J L, Xiong L, Zhou G F,et al. J. Nanosci. Nanotechnol., 2010,10(10):6313-6317
-
[12] CHENG Ling-Zhong(成令钟), ZHONG Cui-Ping(钟翠萍), CAI Wen-Qin(蔡文琴). Contemporary Histology(现代组织 学). Shanghai: Scientific and Technological Literature Publishing House, 2003.[12] CHENG Ling-Zhong(成令钟), ZHONG Cui-Ping(钟翠萍), CAI Wen-Qin(蔡文琴). Contemporary Histology(现代组织 学). Shanghai: Scientific and Technological Literature Publishing House, 2003.
-
[13] U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry and FDA Premarket and Design Control Reviewers Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management[N]. [2011-08-20]. http://www.fda.gov/ MedicalDevices/ DeviceRegulationand Guidance/Guidance Documents/ucm193096.htm[13] U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry and FDA Premarket and Design Control Reviewers Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management[N]. [2011-08-20]. http://www.fda.gov/ MedicalDevices/ DeviceRegulationand Guidance/Guidance Documents/ucm193096.htm
-
[14] State Food and Drug Administration(国家食品药品监督管 理局). YY/T 0316-2008 Medical devices Application of risk management to medical devices [S]. Beijing: Standards Press of China, 2009.[14] State Food and Drug Administration(国家食品药品监督管 理局). YY/T 0316-2008 Medical devices Application of risk management to medical devices [S]. Beijing: Standards Press of China, 2009.
-
-
扫一扫看文章
计量
- PDF下载量: 0
- 文章访问数: 1052
- HTML全文浏览量: 134

下载: